Stage III Breast Cancer Terminated Phase 2 Trials for Capecitabine (DB01101)

IndicationStatusPhase
DBCOND0031775 (Stage III Breast Cancer)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00148720Capecitabine in Women With Operable Breast CancerTreatment